#76 - Cybin CEO: Doug Drysdale on The Future of Psychedelic Treatments
Listen now
Description
In this episode, we chat with Doug Drysdale, CEO of Cybin. Cybin, is a life sciences company advancing mushroom based psychedelic pharmaceuticals and non-psychedelic nutraceutical products as potential therapies for psychiatric and neurological conditions.
Doug has more than 30 years of experience in the healthcare sector broadly and brings a level of expertise to the psychedelics space that is truly incredible.
More Episodes
What is the future of legal cannabis from a retail / e-commerce perspective? Today's guest, Socrates Rosenfeld, Co-Founder and CEO of Jane Technologies explains. Jane is an e-commerce solution for the Cannabis space that supports nearly 3,000 dispensaries and handles more than 20% of the legal...
Published 12/13/21
Published 12/13/21
Alyson Watson is CEO and co-founder of Modern Health, a mental health unicorn! Modern Health is a global mental health benefits solution for employers that covers the spectrum of mental wellbeing needs from tech enabled solutions to professional support solutions on one platform.
Published 11/02/21
Links
Genres
Artwork or description wrong?
Request an update »
Updates may take a few minutes.
Do you host a podcast?
Track your ranks and reviews from Spotify, Apple Podcasts and more.
See hourly chart positions and more than 30 days of history.
Get Chartable Analytics »
See hourly chart positions and more than 30 days of history.
